Arcus Biosciences, Inc. (NYSE:RCUS) Receives $25.67 Average Target Price from Brokerages
Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has received an average recommendation of “Moderate Buy” from the eleven research firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating […]
Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has received an average recommendation of “Moderate Buy” from the eleven research firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating […]
